[1]
Vincenzi, B., Frezza, A.M., Silletta, M., Dell’Aquila, E., Catania, G., Santini, D. and Tonini, G. 2016. Aprepitant plus palonosetron as salvage therapy for CINV induced by moderately emetogenic chemotherapy in cancer patients:  . Cancer Breaking News. 4, 1 (Mar. 2016), 20–25. DOI:https://doi.org/10.19156/cbn.2016.0005.